Elderly patients with fluoropyrimidine and thymidylate synthase inhibitor-resistant advanced colorectal cancer derive similar benefit without excessive toxicity when treated with irinotecan monotherapy

Elderly patients are recommended to have a reduced starting dose (300 mg m(−2) once every 3 weeks) of irinotecan monotherapy. The aims of this analysis are to compare toxicity and survival according to age, performance status (PS), gender and prior radical pelvic radiotherapy (RT). The primary end p...

Descripción completa

Detalles Bibliográficos
Autores principales: Chau, I, Norman, A R, Cunningham, D, Waters, J S, Topham, C, Middleton, G, Hill, M, Ross, P J, Katopodis, R, Stewart, G, Oates, J R
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2004
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409923/
https://www.ncbi.nlm.nih.gov/pubmed/15365570
http://dx.doi.org/10.1038/sj.bjc.6602169

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409923/
https://www.ncbi.nlm.nih.gov/pubmed/15365570
http://dx.doi.org/10.1038/sj.bjc.6602169

Ejemplares similares